首页> 美国卫生研究院文献>other >Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma
【2h】

Effects of microRNA-21 on apoptosis by regulating the expression of PTEN in diffuse large B-cell lymphoma

机译:调节弥漫性大B细胞淋巴瘤中PTEN表达的作用对microRNA-21的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diffuse large B-cell lymphoma (DLBCL) is an aggressive malignancy and the most common subtype of non-Hodgkin lymphoma in China. However, many cases still remain biologically and clinically heterogeneous, indicating that the DLBCL mechanism remains unclear. MicroRNAs (miRNAs) are critically responsible for lymphomagenesis. We found that plasma miR-21 level was significantly higher in B-cell lymphoma. However, the exact contribution of miR-21 in DLBCL remains unknown.To determine the function and mechanism of miR-21 in DLBCL, miR-21 and phosphatase and tensin homolog (PTEN) expressions were examined through real-time PCR and immunohistochemical methods. Moreover, the effects of antisense oligonucleotide (ASO) targeting miR-21 (ASO-21) were observed in DLCBL cell line.MiR-21 expressions in cell line and tissues of patients were significantly higher than those in normal controls, which were inversely correlated with PTEN expression. MiR-21 expression was significantly higher in stage III/IV patients than in stage I/II patients. PTEN protein was expressed positively in only 6 patients with DLBCL (6/26). MiR-21 expression level in the PTEN-negative group was 11.73 (2.13–64.29), which was significantly higher than that in the PTEN-positive group (1.04, 0.67–15.15; P = .038). After down-regulating the miR-21 expression, apoptosis of DLBCL cells increased and PTEN protein was up-regulated in ASO-21-treated cells compared with SCO-21-treated cells by western blot.These results suggested that miR-21 affects apoptosis of lymphoma cells by regulating the expression of PTEN in DLBCL, which may be associated with increased poor prognosis for DLBCL patients and represents a useful approach for DLBCL treatment.
机译:弥漫性大B细胞淋巴瘤(DLBCL)是一种侵袭性恶性肿瘤,是中国非霍奇金淋巴瘤最常见的亚型。但是,许多病例在生物学和临床上仍保持异质性,表明DLBCL机制尚不清楚。微小RNA(miRNA)对淋巴瘤的形成至关重要。我们发现血浆miR-21水平在B细胞淋巴瘤中明显更高。然而,miR-21在DLBCL中的确切作用仍是未知的。为了确定miR-21在DLBCL中的功能和机制,通过实时PCR和免疫组化方法检查了miR-21以及磷酸酶和张力蛋白同源物(PTEN)的表达。此外,在DLCBL细胞系中观察到了针对miR-21(ASO-21)的反义寡核苷酸的作用.miR-21在患者细胞系和组织中的表达明显高于正常对照组,且呈负相关。与PTEN表达。在III / IV期患者中,MiR-21表达明显高于I / II期患者。 PTEN蛋白仅在6例DLBCL患者中阳性表达(6/26)。 PTEN阴性组的MiR-21表达水平为11.73(2.13–64.29),显着高于PTEN阳性组的MiR-21表达水平(1.04,0.67–15.15; P = 0.038)。通过Western印迹分析,与SCO-21处理的细胞相比,下调miR-21的表达后,DLBCL细胞的凋亡增加,而ASO-21处理的细胞中PTEN蛋白上调。这些结果表明miR-21影响细胞凋亡。通过调节DLBCL中PTEN的表达来检测淋巴瘤细胞,这可能与DLBCL患者的不良预后增加有关,是DLBCL治疗的一种有用方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号